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Multipotent Mesenchymal Stem/Stromal cells (MScs) are widely used in cellular therapy for joint 
repair. However, the use of MSC therapies is complicated by a lack of understanding of the behaviour 
of cells and repair within the joint. Current methods of MSC tracking include labelling the cells with 
Super Paramagnetic Iron Oxide nanoparticles (SPIOs). However, standard acquisition sequences (T2 and 
t2*) give poor anatomical definition in the presence of SPIOs. To avoid anatomical compromise in the 
presence of SPIOs, we have investigated the use of Ultra-short Echo Time (UTE) MRI, using a 3D cones 
acquisition trajectory. This method was used to track SPIO labelled MSC injected into joints containing 
osteochondral defects in experimental sheep. this study demonstrates that multiple echo times from 
UTE with 3 T MRI can provide excellent anatomical detail of osteochondral defects and demonstrate 
similar features to histology. This work also monitors the location of SPIO-labelled cells for regenerative 
medicine of the knee with MRI, histology, and Prussian blue staining. With these methods, we show 
that the SPIOs do not hone to the site of defect but instead aggregate in the location of injection, which 
suggests that any repair mechanism with this disease model must trigger a secondary process.
Osteoarthritis (OA) is the most common disease affecting the synovial joints. OA causes significant welfare and 
economic burden in both animal and human healthcare1. A significant cause of OA is articular joint surface 
defects (OA). New strategies for tissue engineering may be able to influence joint surface defect healing2–10. These 
strategies include cell based therapies and small molecular treatments, which have been widely used in regenera-
tive medicine2–10. The development of these methods have, however, been hampered by the difficulty in probing 
their underlying mechanisms. New technology is required to investigate the mechanisms by which joint repair 
occurs, particularly imaging technology for the whole-joint investigation of cellular treatments.
Multipotent Mesenchymal Stromal/Stem Cells (MSCs) are progenitor cells, which can be procured from 
numerous tissues in the body, such as fat and bone marrow11. MSCs can develop into musculoskeletal cells, such 
as osteocytes, chondrocytes, and adipocytes12,13. Whilst MSCs have been used widely in the treatment of joint 
disease14,15, the mechanism of action for MSCs remain an area of research and debate. Proposed mechanisms of 
MSC repair include: paracrine action for recruiting nearby cells; exosome/microvesicle or tunneling nanotube 
exchange for differentiation into replacement cell types; and differentiation and integration within the resident 
tissues16,17.
Irrespective of the mechanism of action of MSC, there is a significant body of research that demonstrates 
the efficacy of MSC in treating such joint pathology as meniscal regeneration18 and osteoarthritis19,20. These 
results indicate that intra-articular MSC injections could represent a genuine therapeutic strategy for joint 
disease. However, the successful launch of MSC therapy as a therapeutic treatment is complicated by a lack of 
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understanding of cellular behaviour within the joint. The lack of sensitive functional tools that can be used to 
measure cells after injection impedes in vivo cell fate tracking, especially within deep tissues.
Cellular tracking can be done in vivo by labelling the cells, injecting them into the joint, and monitoring 
them using specific imaging techniques21. The successful interpretation of these cell tracking experiments relies 
on the sensitivity and specificity of the imaging modality. Magnetic Resonance Imaging (MRI) of cells labelled 
with superparamagnetic iron-oxide (SPIO) particles has been shown to detect single cells22,23, and thereby enable 
tracking of MSC infiltration24–27. The tracking of SPIO-labelled MSCs has been performed in many tissues includ-
ing the myocardium, liver, and the central nervous system6–10, as well as in joints2–5. SPIOs enable cellular tracking 
by increasing the R2 and R2* relaxivities in MRI, compared to normal tissue10. SPIO-labelled MSC tracking in 
musculoskeletal regions is complicated by both the fast (=short) signal relaxation times of both bone and SPIOs, 
which creates signal loss with standard MRI sequences. A high concentration of SPIOs can reduce the MRI signal 
decay, or transverse relaxation times, sufficiently to make tissue completely invisible10,28. The challenge is the vis-
ualisation of these tissues and their subsequent repair in these bony regions.
A method for visualising SPIO-induced signal loss and bone structure is to use an MRI readout with UTE 
k-space sampling, such as 3D cones29. 3D cones uses three dimensional spiral acquisition trajectories that are 
interleaved to efficiently image a volume29. 3D cones can also be acquired with different TEs to enable quantitative 
R2* (=1/T2*) mapping. A 3D cones readout can improve the SPIO labelled MSCs, whereas standard Cartesian 
k-space readouts may result in poor image quality. The aim of this study was to evaluate the use of 3D cones MRI 
sequences for SPIO detection and for visualizing subsequent joint changes after the introduction of SPIO-labelled 
MSCs in an experimentally created osteochondral defect in a large animal preclinical model.
Results
Both histology and Prussian Blue staining confirmed the presence of SPIOs in the fat pad and surrounding syno-
vial fluid, where there was significant MRI signal decay. MSCs were not detected in other regions with any of these 
methods, specifically, at the site of the defect where MSCs were believed to hone. The investigation of this MSC 
and OA model suggests that MSCs do not differentiate, otherwise they would hone to the defect. If these MSCs 
are involved in repair, the mechanism of action would be in the recruitment of secondary cells.
We used three quantitative MRI techniques that showed no effect of the MSCs on R2* or R2 quantitation 
outside of the fat pad. Amongst these techniques, we used a UTE sequence with five echo times or repeats of the 
k-space trajectory within a single repetition time (TR) for quantification of R2*. The UTE sequence also enabled 
visualisation within bone in the presence of SPIOs.
Surgery. The surgical procedures and animal recovery were uneventful. The post-mortem joints did not 
demonstrate osteophyte formation, nor joint degeneration outside of the defect.
Localization of Spios in histological sections. Fluorescent microscopy and Prussian Blue staining were 
used to localize SPIOs within the joint. No cell labelled SPIOs could be detected in the osteochondral defects in 
any of the animals studied. However, SPIOs were detected within the synovium in all animals (Fig. 1).
Localization of focal injection of Spios. MRIs of the site were obtained using a standard 3D cones UTE 
and Cartesian mGE acquisitions, following a focal injection of SPIO-labelled MSC into the suprapatellar fat pad 
of the stifle joint, are shown in Fig. 2. These images demonstrate heavy signal attenuation and a blooming artefact, 
indicating the presence of high concentrations of SPIOs. The high SPIO concentration causes a much larger loss 
of anatomical definition in the Cartesian mGE acquisition, whilst in the 3D cones image significantly more ana-
tomical detail is seen. Signal relaxivity rates were not calculated in these areas with significant blooming, as the 
signal at the first TE was not sufficient to be able to obtain an appropriate fit.
Figure 1. Synovial membrane from the joint of a sheep five weeks after the creation of an osteochondral defect: 
SPIO labelled MSC injection occurred four weeks after defect creation; animal sacrifice occurred one week 
following the injection of SPIO labelled MSCs. These sections show the presence of SPIOs (white arrow) in the 
synovial membrane with (A) fluorescence microscopy, (B) Prussian Blue staining (monochrome image), and 
(C) as a merged image. Scale bar = 75 μm.
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Effect of SPIO-labelled MSC on R2*. Quantification of signal was performed in order to determine the 
effect of the presence of SPIO labelled MSC in the stifle joints in 3D cones acquired images. In the stifles in which 
SPIO labelled MSCs were injected, there was a small R2* relaxivity rate decrease with poor significance in the 
joint space when compared to non-injected stifles (R2* = 64 ± 6 s−1 w/SPIOs; 70 ± 7 s−1 w/o SPIOs, p-value = 
0.10) (Figs. 3 and 4).
Labelled and unlabelled cells visualized with 3D cones MRI. The study was designed to investigate 
whether SPIO-labelled MSCs could be detected in osteochondral defects using 3D cones based MRI in both an 
acutely inflamed joint (cells injected 1 week post surgery) and in a healing joint in which the inflammation has 
begun to wane (cells injected 4 weeks post surgery)30. The acutely inflamed joint has a higher level of inflamma-
tory cytokines and enhanced cellular infiltration, which could lead to altered host/MSC interactions. Therefore, 
the results of the novel MR sequences were considered at two time points. No significant differences were 
observed in the presence of SPIOs between the 1 week and 4 week post surgery animals with any measurement.
3D cones images are shown in Fig. 4 comparing sheep with unlabelled MSCs and SPIO-labelled MSCs in 
order to identify the effect of MSCs with and without SPIOs. Images at three echo times (TE = 0.03, 4.0, 16.1 ms), 
as well as a difference image between the first and second echo time, are shown in order to observe the possible 
SPIO and/or MSC induced changes more closely. No significant differences were observed at the site of the defect 
in joints that were injected with MSCs +/−SPIOs, nor in control joints in which no MSC were injected (Fig. 4).
Histology and MRI. The 3D cones images matched the histology detail of the recovered osteochon-
dral defects with good detail (Figs. 5 and 6). Within the osteochondral defect, 3D cones images at both early 
(0.03 ms) and late (0.16 ms) echo times had similar intensities to muscle tissue, indicating a lack of SPIOs in the 
defects (Fig. 5). The 3D cone images demonstrated the presence of anatomical features of the healing defects 
that were observed in the histological images, with the highest anatomical detail being demonstrated following 
post-acquisition processing (Fig. 5). A difference between the first and last UTE MR images showed features 
that matched well with histology, demonstrating bone, fibrous repair tissue, bone tissue formation, and cartilage 
(Figs. 5 and 6). Although the images between 1 week and 4 week animals appear different in Fig. 5, these features 
were not unique to either time point when viewed across the population. In addition, the UTE MR images show 
additional details with the intermediate echo times, which were not readily apparent on histological samples 
(Fig. 6).
Figure 2. Magnetic resonance images (A–F) relaxation time maps. Images (A,B,D,E) were obtained with 
standard Cartesian sequences; images (C,F) with 3D cones. Images acquired from the same specimen showing 
the appearance of a focal injection of SPIO-labelled MSCs into the suprapatella fat pad of an ovine stifle. The 
SPIOs are seen as a blooming artifact in the cranial aspect of the femoral-tibial joint in both images (white 
arrows).
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Discussion
The aim of this study was to demonstrate the utility of a novel MRI method for imaging SPIO-labelled MSCs 
and their subsequent effects in an ovine osteoarthritic model represented by joint defects. Signal decay increases 
following the introduction of SPIOs and is difficult to measure in bone, which itself has rapid signal decay. This 
signal loss interferes with the interpretation of MRI cell tracking with standard acquisition schemes, such as 
Cartesian readouts. The 3D cones images were able to reduce SPIO artefact and match histology within bone. 
The images also showed bone/cartilage features on intermediate echo images that were not visible on histology. 
The 3D cones MRI method provides excellent anatomical detail of joint defects, and reduces the signal loss from 
SPIO aggregation that was observed in surrounding tissues. UTE MRI methods, such as 3D cones, should be con-
sidered in future SPIO-labelled cell tracking experiments to improve visualisation and relaxation measurements.
MRI gave a clear indication of where the MSCs were located and was unable to detect MSCs in regions beyond 
the fat pad or synovial fluid allowing us to confirm that MSCs were not in other regions. This is clinically useful 
as it is not feasible to perform histological measurements that involve tissue sectioning and disruptive surgery. 
We conclude that if the MSCs do hone to the osteochondral defect, they may do so at a much earlier time point 
than a week after surgical creation of the defect. In a natural in vivio situation while differentiation and honing to 
the defect is possible after seven days, this would be tracking of descendent cells, due limited lifespan of MSCs.
SPIO-labelled MSCs have been previously demonstrated to be present for up to 60 days in the brain31, 42 days 
in the myocardium32 and 28 days in joints33. These31–33 were for longer durations that we were investigating in 
this study, although our study did not show SPIOs in the defects at one week after injection. A longitudinal study 
is suggested with earlier time points to confirm whether there are earlier honing effects. An in vivo longitudinal 
study was not performed due to insufficient access to a 3 T MRI research system that permissed live animal 
imaging; an ex vivo longitudinal study was not performed as that requires an initial proof of concept study to 
demonstrate a relationship between 3D cones MR imaging and histology. This study indicates that both earlier 
and longer term effects of injected MSC should be further investigated.
Figure 3. Summary of the mean relaxivity rates (where the top of each bar indicates the mean) and standard 
deviations (indicated in one direction by the ‘T’ beyond each bar plot). These are listed for (A) R2 with FSE, (B) 
R2* with a Cartesian mGE, (C) R2* with multi-echo 3D Cones, and signal loss ratios of 3D cones between (D) 
the first and second echo, (E) the first and fifth echo, and the (F) the second and fifth echo. A plus ‘+’ indicates 
the measurements in joints injected with SPIOs; a negative ‘−’ indicates the lack of SPIOs; a star ‘*’ indicates if 
the t-test p-value was below 0.15.
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The signal in the lateral fat pad, synovial region between the menisci, or defect is not higher in the sheep knees 
injected with SPIOs compared to those without SPIOs. While SPIOs were clearly visible in concentrated areas 
(Fig. 2), the relaxation rates and decay ratios were lower in the three mentioned ROIs, with 3D Cones relaxation 
rates lower by 6–10%, although this has low significance (p-value = ~0.1). An increase of relaxation rates was seen 
in these areas with FSE R2 with much worse significance (p-value > 0.4). The presence of SPIOs would increase 
these relaxation rates above the rates in the joint without SPIOs, suggesting that there are not sufficient SPIOs 
remaining in these areas a week after injection.
The results of our study of 3D cones at multiple echo times demonstrates a high level of anatomical detail 
is retained even in the presence of SPIOs. Tracking SPIO labelled MSCs with UTE MRI has been previously 
reported in a rodent tumor model27, but has not been shown in musculoskeletal applications, nor shown in a 
large animal model. Standard acquisition schemes using Cartesian readouts cause bony and SPIO induced signal 
loss, thereby interfering with the interpretation of MRI cell MR imaging and tracking. Imaging of SPIO-labelled 
MSC has been reported by several authors in a number of different tissues25–27,34. Previous MSC SPIO imaging 
studies in the joints of experimental animals have typically measured T2* with Cartesian gradient echo where 
the anatomical fidelity is compromised in the presence of SPIOs25,26. However, imaging of SPIO-labelled cells 
in joints poses a imaging challenge due to the presence of dense bone, whether subchondral and osteoarthritic, 
and, if present, of the highly magnetic SPIOs that appears present in nearby fluid capsules. This difficulty has led 
to previous studies raising questions over the specificity of the sequences used for SPIO imaging in the joint34.
Using ovine stifles presented a number of technical challenges including the smaller size of the joint and 
thickness of cartilage. The dimensions of the ovine stifle region (wider in the dorsal-ventral direction and thin-
ner in the left-right direction, when compared to human knees) required a 12-channel head coil to optimise for 
signal-to-noise by minimizing the coil distance to tissue. Other available coils, such as a human knee coil, were 
not sufficiently large for the stifle. An optimized coil, which would be similar to an abdominal coil with smaller 
loop dimensions, could further improve the signal-to-noise. Due to the 3D acquisition of 3D cones, additional 
consideration must be given for the larger required field-of-view to prevent image aliasing.
Figure 4. Ovine stifles imaged with 3D cones four weeks post creation of an osteochondral defect in the distal 
femoral condyle. (A–D) Joints that received an injection of SPIO-labelled MSCs 1 week post-surgery; (E–H) 
Joints that received an injection of unlabelled MSCs 1 week post-surgery; (I–L) Joints that did not have MSCs 
injected. (A,E,I) were imaged at TE = 0.03 ms; (B,F,J) were imaged at TE = 4.0 ms; (C,G,K) were imaged at 
TE = 16.1 ms. (D,H,L) represents the subtraction image of the first two TEs, highlighting the difference between 
(A,E,I,B,F,J). The defect has either similar or higher signal intensity than bone in the single echo time/column 
(A,E,I), regardless of method. The introduction of SPIOs do not cause increased defect decay, which would 
make the image in (C) darker.
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One limiting factor for the 3D cones readout is the MRI system performance, due to the intensive memory 
and computational requirements during both acquisition and reconstruction. Also, in order to be considered 
viable for future longitudinal studies, the scan time was constrained to be less than 10 minutes. Longer scanning 
times would result in higher resolutions, although at the time of acquisition, even higher resolutions were lim-
ited to the memory available on the MRI system, due to the computational requirements of both acquiring and 
reconstructing the data. The slice thickness and resolution was lower for the 3D cones readout (0.56 × 0.56 × 3.0 
mm3) compared to the Cartesian readout (0.35 × 0.35 × 1.5 mm3), and the total acquisition time was nearly twice 
as long. At the time of experiment, the MR system has limited memory requirements for the loading of large, 
arbitrary gradient waveforms. These requirements limited the number of spirals used during the readout, and the 
achievable resolutions during acquisition. Memory is also a requirement for online reconstruction, although is 
less performance critical to driving the MRI system. Online reconstruction finished within five minutes of data 
acquisition on a DV24 GE platform. Despite these performance limitations, the 3D cones images corresponded 
well with histological samples.
Figure 5. 3D cones images of the osteochondral defect created in ovine distal femoral condyles (A–D,F–I) and 
(H&E) stained histological sections of the corresponding osteochondral defect (E,J). Each row is a different 
animal. Images (A–E) were obtained from an animal imaged two weeks post-surgery (one week post surgery; 
one week post MSC injection); images (F–J) were obtained five weeks post-surgery (four weeks post surgery; 
one week post MSC injection). (A,F) were obtained with TE = 0.03 ms; (B,G) were obtained with TE = 4 ms; 
(C,H) were obtained with TE = 16.1 ms. (D,I) are obtained by subtraction of the TE = 0.03 ms and TE = 4 ms 
signal images, which highlights regions that have slow signal decay [hypointense] compared to fast signal decay 
[hyperintense]. Excellent correlation exists between the 3D cones sequences and the histological sections, 
particularly in the subtracted images (D,I). No significant presence of SPIOS are detected in the defect, which 
would be indicated by higher signal loss in TE = 16.1 ms images. Scale bar = 500 μm.
Figure 6. (A) 3D cones subtraction image of the osteochondral defect created in an ovine distal femoral and 
(B) H&E stained histological section of the corresponding osteochondral defect. These images were obtained 
two weeks post surgery, after SPIOs had been present for one week. The image in (A) represents the image 
subtraction between TE = 0.03 ms and TE = 4 ms images (see Fig. 6). This figure demonstrates the high degree 
of correlation between the MR image and the histological appearance of the tissue.
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The mechanism by which MSCs exert an influence in healthy and diseased tissues still remains unknown. 
Early reports described MSCs ‘honing’ to a defect and contributing to ‘building blocks’ for tissue regeneration35. 
However, in vivo studies using MRI tracking of SPIO-labelled MSCs have failed to provide any evidence of this 
honing – in both osteoarthritic models and joint defect models, with SPIO signals largely being confined to the 
synovium25, as reported in this study. Whilst MSCs may not contribute directly to the re-building of damaged tis-
sue, a body of evidence supports a role in modifying and mediating disease. Increasing evidence strongly suggests 
that MSC exert a paracrine effect on resident cells36, possibly via the intermediary of MSC derived extracellular 
vesicles (EVs)37. EVs from MSCs have been shown to contain a number of biologically active factors and have, 
alone, been shown to have beneficial effects on pathology38. If EVs are the ‘active agent’ of MSC, then tracking and 
understanding their distribution within target tissues such as joints becomes, as with MSC tracking, a significant 
issue. The development and validation of sensitive MRI methods such as described in this study will be key to 
understanding MSC biology.
This study has shown that using 3D cones for tracking SPIO-labelled MSC generates MR images of high ana-
tomical detail, evidenced by a similar image features between the MRIs and the histological evaluation of ovine 
joints. The superior structure detection of this method over standard Cartesian MRI acquisitions is a unique 
strength of UTE MRI provided by 3D cones, which we would like to use for future longitudinal monitoring 
of both clinical and experimental joint surface defect healing. UTE methods will enable us to further validate 
biological healing of small osteochondral defects, which are difficult to image due to their small size and the fast 
MRI signal decay rates of bones and SPIOs. Confirmation of the correlation between MRI and histology will help 
future studies monitor not only MSC locations, but also monitor the effects of mesenchymal stem/stromal cell 
healing of damaged tissues.
Methods
Animals. Seven mature female Welsh Mountain Sheep were used in this study with approval from from both 
the Animal Welfare and Ethical Review Body, University of Cambridge and the UK Home Office Project Licence 
number 70–7740. All methods were performed in accordance with the relevant guidelines and regulations30.
Bone marrow harvest. Autologous MSCs were isolated by bone marrow aspiration from the iliac crest 
of anesthetized animals and collected in αMEM containing 10% FBS, 1% L-glutamine (LG), 1% antibiotic and 
anti-mycotic (AA) and a heparin sodium solution to prevent clotting (5000 IU/ml, Wockhardt, Wrexham, UK). 
The aspirate was then transported on ice for downstream MSC isolation30.
cell isolation and expansion. From the aspirate, autologous ovine MSCs were isolated by red blood 
cell (RBC) lysis treatment and subsequent growth occurred within αMEM media containing 20% FBS, 1% 
L-Glutamine and 1% AA for 1 day before further media changes. MSCs were subsequently cultured under stand-
ard cell culturing conditions in αMEM expansion media (EM; 10% FBS, 1% L-glutamine and 1% AA) until pas-
sage 2 as previously described for sheep MSC30.
Spio labelling of MScs. MSCs were labelled with Nanomag-D (Micromod, Germany), a commercially 
available 250 nm SPIO with COOH functionality and using the cell penetrating peptide P218R (gifted from 
the University of Nottingham), that we have previously demonstrated does not interfere with cell growth or 
differentiation capacity [30] and that is retained within the cells over the experimental time period [30]. Cells 
were labelled at a ratio of 25 µg of Nanomag (1 mg/ml) per 2 × 105 cells and complexed with 1 µl (1 mM) P218R 
per 50 µg Nanomag. In brief, MSCs (P2) were seeded in T175 flasks at 80% confluency in EM and allowed to 
attach overnight. Media was then replaced with the labelling solution (consisting of serum free media (SFM) 
and the appropriate amount of Nanomag+P218R) and cells incubated overnight at 37 °C and 5% CO2 to ena-
ble efficient internalization of Nanomag. Following this, cells were washed thoroughly in PBS (3×) to remove 
non-internalised Nanomag. Nanomag uptake was confirmed with Prussian Blue staining of dried and fixed cells30.
Surgical procedure. The left stifle joints of each animal were opened via a parapatellar approach with the 
animals under general anaesthesia. An 8 mm diameter, 8 mm deep, osteochondral defect was created in the 
medial femoral condyle (MFC) in the right stifle joints of each animal under strict asepsis. The defects were 
centralised in the medial femoral condyle, aligned with the medial crest of the trochlear groove and 10 mm distal 
to the condyle groove junction. After surgery, the joints were closed in routine fashion, and the animals were 
allowed to fully bear weight post-operatively30.
cell delivery. Prior to delivery, Nanomag+P218R labelled cells were stained with CM-DiI (Molecular Probes, 
Paisley UK) a fluorescent cell tracker as described previously30. 107 labelled cells were subsequently re-suspended 
in 2 ml SFM containing 1% LG and1% AA30. The animals received labelled MSC injections in the left joint 
and unlabelled MSC injections in the right joint. Injections into the femoro-patella joint occurred at one week 
post-surgery (n = 4) and four weeks post-surgery (n = 6). One animal received a focal injection of MSC into the 
supra-patella fat pad 1 week post-surgery. Animals were humanely killed with an overdose of anaesthetic one 
week after MSC injection.
Magnetic resonance imaging. Imaging was performed on the post mortem operated stifles using a 
12-channel head receive-only coil on a 3.0 T MRI system (MR750 GE Healthcare, Waukesha, WI, USA). This coil 
provided a large volume in order to cover the length of the stifle.
Sagittal UTE images were acquired with a 3D cones k-space acquisition using a multi-echo gradient echo 
(mGE) sequence. The sequence repeated five k-space readouts at each TE and within a single repetition time 
(TR) for R2* quantification. The field-of-view (FOV) was 180 mm × 180 mm using a reconstruction matrix = 
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320 ×320, bandwidth = ±62.50 kHz, slices = 36, slice thickness = 3.0 mm, points per interleaf = 452, number of 
spiral interleaves = 442, averages = 1, TR = 23 ms, TEs = 0.03, 4.0, 8.1, 12.1, 16.1 ms, flip angle = 15°, and total 
scan time = 6 minutes 6 seconds for all echoes.
Sagittal Cartesian 3D mGE images were also obtained for quantitative R2* MRI, using the Susceptibility 
Weighted Angiography (SWAN) pulse sequence39,40. The scan parameters were FOV = 180 mm × 162 mm, recon-
struction matrix = 512 × 460, bandwidth = ±195 kHz, flip angle = 20°, slices = 72, slice thickness = 1.5 mm, 
TR = 40.7 ms, using TEs = 7.0, 12.8, 18.5, 24.3, 30.1, 35.8 ms, which were the used 70% asymmetric sampling, coil 
acceleration (ASSET) = 2, and total scan time = 3 minutes 7 seconds.
Sagittal Cartesian 3D fast spin echo (FSE) imaging was performed with multiple MLEV (Malcolm Levitt’s 
composite-pulse decoupling) preparations for R2 mapping. The FSE preparation for R2 measurements consisted 
of a non-selective MLEV train of equally separated (+)90°–180°-(−)90° pulses41. The sequence parameters were 
FOV = 180 mm × 180 mm, reconstruction matrix = 320×320, slices = 72, slice thickness = 3.0 mm, band-
width = ±78.08 kHz, flip angle = 20°, TR = 1920ms, TEs = 2.8, 31.7, 63.8, and 112 ms, echo train length = 
45, coil acceleration (ASSET) = 2, 50% partial Fourier phase encoding (half-NEX), total scan time = 6 minutes 
56 seconds.
image processing. Relaxation maps were calculated using a linear least-squares regression created using 
the Python NumPy package (NumPy Version 1.11.0, Python Software Foundation, https://www.python.org/).
The ratio of the UTE signals was also calculated as a secondary measurement of R2* signal decay. Cartilage has 
multiple R2 (or R2*) components42, which would not be captured by an R2* map using all TEs42,43. More interme-
diate TEs should be measured In order to properly measure multi-exponential decay rates with values interme-
diate to the first and second TE, or shorter than the first TE. The ratio of UTE signal loss is defined here such that 
it correlates with R2*, where the signal decay ratio presented below, R, increases with increased relaxation rates. 
A two-point R2* estimate can be obtained through the negative logarithm of these values minus one. These UTE 
signal ratios were calculated as
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The means and standard deviation of each relaxation map was calculated in five regions-of-interest (ROIs), 
which included: the synovial joint space between the menisci; the fat pad; the bone on the tibial plateau between 
the cartilage and physis; a large region of dorsal muscle; and the defect containing region, or a similar region of 
bone in sheep without the defect. This ratio represents the signal loss between two echoes, where it is equal to 
unity when 100% signal loss has occurred and zero when no signal has been lost between echo times.
Significance test. A t-test was performed on each tissue to compare between the relaxation values with and 
without SPIOs. Significance was considered if the t-test p-value was below 0.15.
Histology. After imaging, the osteochondral defect sites were retrieved and decalcified in formic acid/sodium 
citrate over 4 weeks, prior to routine paraffin processing. Sections through the central portions of the defect were 
made 10 μm thick and stained with Prussian Blue and Haematoxylin and Eosin. Fluorescent and direct light 
microscopy was used to identify the presence of SPIOs and tissue architecture.
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